Skip to content
The Policy VaultThe Policy Vault

Livmarli (maralixibat)United Healthcare

Progressive Familial Intrahepatic Cholestasis (PFIC)

Initial criteria

  • Diagnosis of progressive familial intrahepatic cholestasis (PFIC)
  • Patient is experiencing pruritus associated with PFIC

Reauthorization criteria

  • Documentation of positive clinical response to Livmarli therapy

Approval duration

12 months